Polymeric Microparticles Core-Shell Structure Crosslinking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing microcarriers used in cell culture and biopharmaceutical applications face challenges such as high manufacturing costs, reduced economic efficiency, and potential cell damage due to the need for proteolytic enzyme-based cell detachment processes. Additionally, biopolymers like hyaluronic acid are prone to decomposition and have reduced cell adhesion in biological environments.
Innovation Solution
A method for preparing polymeric microparticles with a core-shell structure, involving a biocompatible polymer mixture of hyaluronic acid and gelatin, which is crosslinked using metal ions and further stabilized with an organic crosslinking agent in a polar solvent phase, enhancing mechanical strength and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hyaluronic acid is used as a biocompatible polymer, then cell adhesion and biocompatibility are improved, but mechanical strength and stability deteriorate due to easy decomposition
Solution Approach 1:
The patent combines hyaluronic acid with gelatin and applies crosslinking agents (glutaraldehyde, genipin, or lysine) to create a composite microcarrier system. This composite structure maintains the biocompatibility of hyaluronic acid while adding the mechanical strength and stability of gelatin and crosslinked networks, resolving the contradiction between softness and structural integrity
Solution Approach 2:
The patent modifies the chemical parameters of hyaluronic acid through crosslinking reactions. By introducing crosslinking agents that form covalent bonds between polymer chains, the physical and chemical properties of hyaluronic acid are altered to enhance mechanical strength, thermal stability, and resistance to decomposition while preserving biocompatibility
2Strength
If gelatin is used to improve mechanical strength, then physical properties are improved, but temperature sensitivity and enzyme susceptibility worsen
Solution Approach 1:
The patent creates a composite system where gelatin is combined with hyaluronic acid and crosslinked with specific agents. This composite approach allows gelatin to provide mechanical strength while the crosslinked network and hyaluronic acid component compensate for temperature sensitivity and enzyme susceptibility, achieving both strength and stability
Solution Approach 2:
The patent applies different crosslinking mechanisms to different aspects of the microcarrier structure. Crosslinking agents target specific functional groups in gelatin and hyaluronic acid to create a heterogeneous network with locally optimized properties: strong crosslinks for mechanical strength, dense crosslinks for stability, while maintaining overall biocompatibility
3Strength
If crosslinking density is increased to improve mechanical strength, then particle strength is improved, but cell adhesion capability worsens due to reduced surface functionality
Solution Approach 1:
The patent creates a heterogeneous microcarrier structure where the interior has high crosslinking density for mechanical strength while the surface maintains lower crosslinking density and higher functional group availability for cell adhesion. This local differentiation resolves the contradiction between strength and adhesion capability
Solution Approach 2:
The patent optimizes crosslinking parameters (agent type, concentration, reaction time, temperature) to achieve a balanced crosslinking density that provides sufficient mechanical strength while preserving enough surface functionality for cell adhesion. By carefully controlling these parameters, both strength and adhesion are maximized simultaneously
4Productivity
If conventional microcarriers are used for cell culture, then cell culture capability is improved, but manufacturing cost increases due to required detachment processes
Solution Approach 1:
The patent removes the need for proteolytic enzyme-based detachment processes by designing microcarriers with controlled biodegradability. The microcarriers can be designed to naturally degrade or release cells through physiological processes, eliminating the need for expensive enzyme treatments and reducing manufacturing costs while maintaining cell culture capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting polymeric microparticles exhibit improved mechanical strength, stability, and cell adhesion, reducing manufacturing costs and enhancing biocompatibility, making them suitable for large-scale cell culture and biopharmaceutical applications.
Implementation Method 1
reacting a mixture containing a biocompatible polymer and a metal ion to form crosslinked polymer particles
Implementation Method 2
further crosslinking the crosslinked polymer particles in a polar solvent phase including an organic crosslinking agent containing at least one reactive functional group
Data Source
AI summary
According to the present disclosure, a method of preparing polymeric microparticles comprising further crosslinking with an organic crosslinking agent after crosslinking with metal ions, polymeric microparticles, medical compositions, cosmetic compositions, medical articles and cosmetic articles comprising the same can be provided.